Outcomes of Descemet Membrane Endothelial Keratoplasty

Overview

About this study

The goal of this study is to determine optical and visual function through 5 years after Descemet membrane endothelial keratoplasty (DMEK). The study will also determine graft health (corneal endothelial cell loss) and survival through 5 years after DMEK, and factors associated with these outcomes, as well as assess the relationship between optical and anatomical corneal rehabilitation after DMEK.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Patient age 21 years or older; either sex.
Corneal endothelial disease: Presence of corneal endothelial dysfunction requiring keratoplasty, including pseudophakic corneal edema and Fuchs endothelial dystrophy.
Lenticular status: Pseudophakic with posterior chamber intraocular lens or phakic with or without cataract requiring extraction.

Exclusion Criteria

Uncontrolled glaucoma or prior filtering surgery (tube shunt or trabeculectomy).
Uncontrolled uveitis.
High graft failure risk including herpetic keratouveitis or any condition with two or more quadrants of stromal neovascularization.
Presence of anterior chamber intraocular lens.
Pregnancy
Those unlikely to complete the study due to plans to move, preference to follow-up with local provider, international patients, etc.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Sanjay Patel, M.D.	Closed for enrollment	Contact information: Emily Treichel (507)284-8558 Treichel.Emily@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sanjay Patel, M.D.

Closed for enrollment

Contact information:

Emily Treichel

(507)284-8558

Treichel.Emily@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials